Free Trial
NASDAQ:GBIO

Generation Bio (GBIO) Stock Price, News & Analysis

Generation Bio logo
$0.43 -0.01 (-3.18%)
As of 10:04 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Generation Bio Stock (NASDAQ:GBIO)

Key Stats

Today's Range
$0.43
$0.46
50-Day Range
$0.30
$0.44
52-Week Range
$0.30
$3.65
Volume
219,750 shs
Average Volume
415,655 shs
Market Capitalization
$28.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.33
Consensus Rating
Buy

Company Overview

Generation Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
80th Percentile Overall Score

GBIO MarketRank™: 

Generation Bio scored higher than 80% of companies evaluated by MarketBeat, and ranked 249th out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Generation Bio has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Generation Bio has only been the subject of 1 research reports in the past 90 days.

  • Read more about Generation Bio's stock forecast and price target.
  • Earnings Growth

    Earnings for Generation Bio are expected to grow in the coming year, from ($1.75) to ($0.95) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Generation Bio is -0.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Generation Bio is -0.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Generation Bio has a P/B Ratio of 0.34. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Generation Bio's valuation and earnings.
  • Percentage of Shares Shorted

    1.67% of the float of Generation Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Generation Bio has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Generation Bio has recently decreased by 59.20%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Generation Bio does not currently pay a dividend.

  • Dividend Growth

    Generation Bio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.67% of the float of Generation Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Generation Bio has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Generation Bio has recently decreased by 59.20%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Generation Bio has a news sentiment score of 0.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Generation Bio this week, compared to 1 article on an average week.
  • Search Interest

    2 people have searched for GBIO on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Generation Bio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    21.10% of the stock of Generation Bio is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    95.22% of the stock of Generation Bio is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Generation Bio's insider trading history.
Receive GBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Generation Bio and its competitors with MarketBeat's FREE daily newsletter.

GBIO Stock News Headlines

Generation Bio (NASDAQ:GBIO) Trading 13.9% Higher - Here's Why
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
GBIO Generation Bio Co. - Seeking Alpha
See More Headlines

GBIO Stock Analysis - Frequently Asked Questions

Generation Bio's stock was trading at $1.06 at the beginning of 2025. Since then, GBIO shares have decreased by 58.5% and is now trading at $0.44.

Generation Bio Co. (NASDAQ:GBIO) posted its earnings results on Wednesday, May, 7th. The company reported ($0.22) earnings per share for the quarter, topping analysts' consensus estimates of ($0.25) by $0.03. The business earned $8.72 million during the quarter, compared to the consensus estimate of $1.70 million. Generation Bio had a negative net margin of 292.92% and a negative trailing twelve-month return on equity of 75.84%.

Generation Bio (GBIO) raised $126 million in an initial public offering (IPO) on Friday, June 12th 2020. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. J.P. Morgan, Jefferies and Cowen served as the underwriters for the IPO and Wedbush PacGrow was co-manager.

Shares of GBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Generation Bio investors own include Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Visa (V) and Home Depot (HD).

Company Calendar

Last Earnings
5/07/2025
Today
7/15/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GBIO
CIK
1733294
Fax
N/A
Employees
150
Year Founded
N/A

Price Target and Rating

High Price Target
$9.00
Low Price Target
$5.00
Potential Upside/Downside
+1,566.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.08)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$131.67 million
Net Margins
-292.92%
Pretax Margin
-292.92%
Return on Equity
-75.84%
Return on Assets
-30.40%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
8.43
Quick Ratio
8.43

Sales & Book Value

Annual Sales
$19.89 million
Price / Sales
1.48
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.29 per share
Price / Book
0.34

Miscellaneous

Outstanding Shares
67,040,000
Free Float
52,891,000
Market Cap
$29.50 million
Optionable
Optionable
Beta
2.59
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:GBIO) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners